NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.

[1]  D. Kamnasaran,et al.  Immunohistochemical Analyses of NPAS3 Expression in the Developing Human Fetal Brain , 2011, Anatomia, histologia, embryologia.

[2]  G. Rouleau,et al.  Association of NPAS3 exonic variation with schizophrenia , 2010, Schizophrenia Research.

[3]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[4]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[5]  A. Kaye,et al.  Tumour angiogenesis: Its mechanism and therapeutic implications in malignant gliomas , 2009, Journal of Clinical Neuroscience.

[6]  M. Polymeropoulos,et al.  Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study , 2009, Molecular Psychiatry.

[7]  W. M. Foster,et al.  NPAS3 is a trachealess homolog critical for lung development and homeostasis , 2009, Proceedings of the National Academy of Sciences.

[8]  M. Tate,et al.  Biology of angiogenesis and invasion in glioma , 2009, Neurotherapeutics.

[9]  G. Riggins,et al.  Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling , 2009, Journal of Neuro-Oncology.

[10]  M. Nakao,et al.  Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma. , 2009, Neuro-oncology.

[11]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[12]  S. Brogna,et al.  Nonsense-mediated mRNA decay. , 2008, Biochemical Society transactions.

[13]  C. Chelala,et al.  Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays , 2008, Oncogene.

[14]  Paul Gardina,et al.  Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization , 2008, Genes, chromosomes & cancer.

[15]  G. Turashvili,et al.  Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis , 2007, BMC Cancer.

[16]  J. Little,et al.  Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status , 2007, Acta oncologica.

[17]  G. Broggi,et al.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.

[18]  L. Chin,et al.  Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. , 2006, Cancer research.

[19]  Shuang-yin Han,et al.  c-Jun NH2-Terminal Kinase 2α2 Promotes the Tumorigenicity of Human Glioblastoma Cells , 2006 .

[20]  Yuri Kotliarov,et al.  High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. , 2006, Cancer research.

[21]  J. Squire,et al.  Molecular cytogenetic analysis in the study of brain tumors: findings and applications. , 2005, Neurosurgical focus.

[22]  A. Kaye,et al.  Caspase 8 is absent or low in many ex vivo gliomas , 2005, Cancer.

[23]  D. Brat,et al.  The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Vorhees,et al.  Abnormal neurodevelopment, neurosignaling and behaviour in Npas3‐deficient mice , 2005, The European journal of neuroscience.

[25]  Mitchel S Berger,et al.  Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.

[26]  K. Devriendt,et al.  Defining a holoprosencephaly locus on human chromosome 14q13 and characterization of potential candidate genes. , 2005, Genomics.

[27]  Masha Kocherginsky,et al.  Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. , 2005, Cancer research.

[28]  Carol Dudley,et al.  Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Alona Muzikansky,et al.  The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  G. Fuller,et al.  Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. , 2004, Neuron glia biology.

[31]  J. Herman,et al.  GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer , 2003, Molecular and Cellular Biology.

[32]  N. Socci,et al.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. , 2003, Molecular cell.

[33]  D W Cox,et al.  Disruption of the neuronal PAS3 gene in a family affected with schizophrenia , 2003, Journal of medical genetics.

[34]  R. Jove,et al.  Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells , 2003, International journal of cancer.

[35]  S. Hayashi,et al.  The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors. , 2002, Anticancer research.

[36]  M. Berger,et al.  Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. , 2001, Cancer research.

[37]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[38]  M Reick,et al.  Impaired cued and contextual memory in NPAS2-deficient mice. , 2000, Science.

[39]  D. Witte,et al.  Gene expression pattern Characterization of Npas 3 , a novel basic helix-loop-helix PAS gene expressed in the developing mouse nervous system , 1999 .

[40]  C. Fan,et al.  Remembrance of things PAS: regulation of development by bHLH-PAS proteins. , 1999, Current opinion in genetics & development.

[41]  H. Kataoka,et al.  Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review). , 1999, International journal of molecular medicine.

[42]  A. Cantor,et al.  Extending SAS Survival Analysis Techniques for Medical Research , 1997 .

[43]  Z. Ying,et al.  Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .

[44]  Gerald C. Chu,et al.  Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. , 2008, Cold Spring Harbor symposia on quantitative biology.

[45]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[46]  A. Cantor.  SAS survival analysis techniques for medical research , 2003 .

[47]  R. Strausberg,et al.  A new cancer genome anatomy project web resource for the community. , 2001, Cancer journal.